Yi-Ni Ma1, Li-Xiang Zhang2, Yuan-Yuan Hu3, Tian-Lu Shi1. 1. Department of Pharmacy, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230036, People's Republic of China. 2. Department of Cardiology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230036, People's Republic of China. 3. Department of Endocrinology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230036, People's Republic of China.
Abstract
OBJECTIVE: This study established an individualized nomogram for predicting the risk of multidrug-resistant bacterial (MDRB) infection in patients with the diabetic foot (DF), and providing a reference for clinical prevention and treatment. METHODS: A total of 199 DF patients admitted to the hospital from July 2015 to December 2018 were included in this study. The pathogenic bacteria at the site of infection were detected and the factors affecting the occurrence of MDRB infection in DF patients summarized. The R software was used to draw the nomogram, and the Bootstrap Method used to internally verify the model. The calibration curve and the Harrell's Concordance Index (C-index) were used to evaluate the predictive effect of the nomogram model. RESULTS: Logistic regression analysis showed that age, course of diabetes, previous use of antibacterial drugs, types of antibacterial drugs, and osteoporosis were risk factors for multidrug-resistant infections in DF (P<0.05). The area under the receiver operating characteristic curve (AUC, Area Under Curve) of the nomogram model after internal verification was 0.773 (95% CI: 0.704-0.830). The mean absolute error between the predicted probability of infection in the nomogram and the actual occurrence of MDRB was 0.032, indicating that the nomogram model had good forecasting efficiency and stability. CONCLUSION: The risk factors for multidrug-resistant infections in DF are age, course of diabetes, previous use of antibacterial drugs, types of antibacterial drugs used, and osteoporosis. The nomogram model drawn on these risk factors has good predictive accuracy and can assist medical staff in formulating targeted infection prevention strategies for patients.
OBJECTIVE: This study established an individualized nomogram for predicting the risk of multidrug-resistant bacterial (MDRB) infection in patients with the diabetic foot (DF), and providing a reference for clinical prevention and treatment. METHODS: A total of 199 DF patients admitted to the hospital from July 2015 to December 2018 were included in this study. The pathogenic bacteria at the site of infection were detected and the factors affecting the occurrence of MDRB infection in DF patients summarized. The R software was used to draw the nomogram, and the Bootstrap Method used to internally verify the model. The calibration curve and the Harrell's Concordance Index (C-index) were used to evaluate the predictive effect of the nomogram model. RESULTS: Logistic regression analysis showed that age, course of diabetes, previous use of antibacterial drugs, types of antibacterial drugs, and osteoporosis were risk factors for multidrug-resistant infections in DF (P<0.05). The area under the receiver operating characteristic curve (AUC, Area Under Curve) of the nomogram model after internal verification was 0.773 (95% CI: 0.704-0.830). The mean absolute error between the predicted probability of infection in the nomogram and the actual occurrence of MDRB was 0.032, indicating that the nomogram model had good forecasting efficiency and stability. CONCLUSION: The risk factors for multidrug-resistant infections in DF are age, course of diabetes, previous use of antibacterial drugs, types of antibacterial drugs used, and osteoporosis. The nomogram model drawn on these risk factors has good predictive accuracy and can assist medical staff in formulating targeted infection prevention strategies for patients.
Authors: T Ambrose; L M Sharkey; J Louis-Auguste; C S Rutter; S Duncan; S English; E Gkrania-Klotsas; A Carmichael; J M Woodward; N Russell; D Massey; A Butler; S Middleton Journal: Transplant Proc Date: 2016-03 Impact factor: 1.066
Authors: Anil Hingorani; Glenn M LaMuraglia; Peter Henke; Mark H Meissner; Lorraine Loretz; Kathya M Zinszer; Vickie R Driver; Robert Frykberg; Teresa L Carman; William Marston; Joseph L Mills; Mohammad Hassan Murad Journal: J Vasc Surg Date: 2016-02 Impact factor: 4.268
Authors: Cosmina I Bondor; Ioan A Veresiu; Bogdan Florea; Etta J Vinik; Aaron I Vinik; Norina A Gavan Journal: J Diabetes Res Date: 2016-02-25 Impact factor: 4.011
Authors: Christian Grønhøj; David H Jensen; Christian Dehlendorff; Linda Marklund; Steffen Wagner; Hisham Mehanna; Eva Munck-Wikland; Torbjörn Ramqvist; Anders Näsman; Claus Wittekindt; Nora Würdemann; Shachi Jenny Sharma; Stefan Gattenlöhner; Katalin Kiss; Elo Andersen; Rachel Spruce; Nikos Batis; Max Robinson; Kevin Harrington; Stuart Winter; Terence M Jones; Jens Peter Klussmann; Tina Dalianis; Jeppe Friborg; Christian von Buchwald Journal: Br J Cancer Date: 2018-05-24 Impact factor: 7.640
Authors: Tae Gyun Kim; Sang Young Moon; Moon Seok Park; Soon-Sun Kwon; Ki Jin Jung; Taeseung Lee; Baek Kyu Kim; Chan Yoon; Kyoung Min Lee Journal: J Korean Med Sci Date: 2015-12-24 Impact factor: 2.153